The company, now based in London, announced Tuesday that it has raised $100 million from investors, allowing it to expand its presence to the United States. The exact amounts invested by each company were not disclosed.
Pfizer and BioNTech said they submitted data to the European Medicines Agency, including late-stage results from a study testing their COVID-19 vaccine in more...